HGH FRAGMENT 176-191aa (50MG) ZPHC

HGH Fragment 176-191 — targeted lipolytic peptide
5 lyophilised vials × 10 mg (total 50 mg)

• Selective fat-loss: fragment 176-191 enhances lipolysis and blocks lipogenesis without raising glucose or IGF-1.
• Reconstitution: add 2 ml bacteriostatic water → 5 mg/ml; swirl gently, do not shake.
• Storage: refrigerate 2 – 8 °C once mixed; freeze-dried powder ships safely at room temperature.
• Sample research dosing: 250 – 500 µg sub-Q 1–3 × daily, 30 min pre-cardio, for 4–6 weeks.
• QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; scratch-code authenticity on every box.
• Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery.